Table 1.

Participant demographics

Gender
Male: n (%)	23 (38.3%)
Female: n (%)	37 (61.7%)
Age: mean years (SD)	40 (16)
Disease: n (%)
Ulcerative colitis	7 (11.7%)
Crohn’s disease	53 (88.3%)
Concomitant medications:
α-TNF	53 (88%)
No biologic therapy	6 (4%)
C-reactive protein (SD)
Baseline (n = 59)	6.4 (10.26)
6 months (n = 58)	9.2 (19.88)